Voglio sapere a riguardo di…

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 86, No. 229 / Thursday, December 2, 2021 / Notices Commissions electronic docket EDIS
at http edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.In September 2016, the Commission determined that a U.S.
industry was materially injured by reason of imports of hot-rolled steel flat products from Turkey found by the U.S.
Department of Commerce Commerce to be sold in the United States at less than fair value 81 FR 66996, Sept. 29, 2016.
On September 10, 2021, the Commission received a request to review its affirmative determination in investigation No. 731TA1296 Final pursuant to section 751b of the Act 19
U.S.C. 1675b. The request, filed by Eregli Demir ve Celik Fabrikalari T.A.S.
Erdemir, alleges there have been significant changed circumstances since the issuance of the Commissions 2016
determination. Specifically, Erdemir alleges that Commerces recalculation of Colakoglus antidumping duty margin to zero percent and its exclusion from the antidumping duty order as a result of judicial review constitute significantly changed circumstances from those in existence at the time of the original investigation because the facts underlying the Commissions negligibility determination completely changed. According to Erdemir, the exclusion of Colakoglu from the antidumping duty order places this case in pari materia with the injury case in the countervailing duty investigation and provides a compelling basis to find that imports from Turkey subject to the antidumping duty investigation are negligible.
Written comments requested.
Pursuant to section 207.45b of the Commissions Rules of Practice and Procedure, the Commission requests comments concerning whether the alleged changed circumstances, brought about by the aforementioned changes in the imports of hot-rolled steel flat products from Turkey subject to an antidumping duty order, are sufficient to warrant institution of a review.
The Commission further requests comments concerning the degree to which any changed circumstances proceeding concerning hot-rolled steel flat products from Turkey can be conducted in conjunction with the fiveyear review of the antidumping duty order on the same subject merchandise that Commerce has initiated and the Commission has instituted on September 1, 2021 86 FR 49057. If the Commission initiates a changed circumstances review, the review is likely to be conducted on an overlapping basis with the five-year
VerDate Sep<11>2014

16:49 Dec 01, 2021

Jkt 256001

review concerning hot-rolled steel flat products from Turkey. Therefore, commenters are encouraged to address the nature of the respective inquiries, the data and other information necessary for the Commissions evaluation, and procedural considerations for the effective conduct of the reviews.
Written submissions.Comments must be filed with the Secretary to the Commission by no later than 30 days after publication of this notice or by XXX. All written submissions must conform with the provisions of 201.8
of the Commissions rules; any submissions that contain BPI must also conform with the requirements of 201.6, 207.3, and 207.7 of the Commissions rules. The Commissions Handbook on Filing Procedures, available on the Commissions website at https www.usitc.gov/documents/
handbook_on_filing_procedures.pdf, elaborates upon the Commissions procedures with respect to filings.
Please note the Secretarys Office will accept only electronic filings at this time. Filings must be made through the Commissions Electronic Document Information System EDIS, https
edis.usitc.gov. No in-person paperbased filings or paper copies of any electronic filings will be accepted until further notice.
Authority: This notice is published pursuant to section 207.45 of the Commissions rules.
By order of the Commission.
Issued: November 29, 2021.
William Bishop, Supervisory Hearings and Information Officer.
FR Doc. 202126222 Filed 12121; 8:45 am BILLING CODE 702002P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA888

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022
Drug Enforcement Administration, Department of Justice.
ACTION: Final order.
AGENCY:

This final order establishes the initial 2022 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of
SUMMARY:

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

68513

annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
The initial 2022 aggregate production quotas and assessment of annual needs are effective December 2, 2021.
FOR FURTHER INFORMATION CONTACT:
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701
Morrissette Drive, Springfield, VA
22152, Telephone: 571 7762265.
SUPPLEMENTARY INFORMATION:
DATES:

I. Legal Authority Section 306 of the Controlled Substances Act CSA 21 U.S.C. 826
requires the Attorney General to establish aggregate production quotas for each basic class of controlled substance listed in schedule I and II and for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. The Attorney General has delegated this function to the Administrator of the Drug Enforcement Administration DEA
pursuant to 28 CFR 0.100.
II. Background The 2022 aggregate production quotas APQ and assessment of annual needs AAN represent those quantities of schedule I and II controlled substances and the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine that may be manufactured in the United States in 2022 to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine, and phenylpropanolamine, but do not include imports of controlled substances for use in industrial processes.
On October 18, 2021, a notice titled Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 was published in the Federal Register. 86 FR
57690. This notice proposed the 2022
APQ for each basic class of controlled substance listed in schedules I and II
and the 2022 AAN for the list I
chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. All interested persons were invited to comment on or object to the proposed
E:FRFM02DEN1.SGM

02DEN1